Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.

The 83-year-old made the health admission during the Feb. 18 episode of ‘The View’ ...

An anti-doping group is keeping a close eye on the use of these obesity and diabetes drugs in elite athletes. Here’s why.

“GLP-1 helped me enhance everything that I was already doing — eating healthy and working out,” the tennis champion tells PEOPLE Serena Williams reveals to PEOPLE that she’s been using a GLP-1 ...

A majority of people with overweight or obesity prescribed glucagon-like peptide 1 receptor agonists (GLP-1 RAs) discontinue them within 1 year, with higher quit rates among those without type 2 ...

Please provide your email address to receive an email when new articles are posted on . The guideline has eight points of emphasis on specific elements of lifestyle medicine. PCPs can use them to ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...